Safety of clopidogrel in children with arterial ischemic stroke
Rebecca Ireland
This article has no abstract so we have provided the first paragraph of the full text.
Antiplatelet therapy with aspirin is widely used for the secondary prevention of stroke in patients who have experienced an arterial ischemic stroke (AIS). Long-term use of aspirin, however, can cause gastric and respiratory adverse effects, and resistance to therapy often occurs. Researchers in Canada have investigated the safety and tolerability of clopidogrel, an alternative antiplatelet treatment, in children with AIS.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.